Compounds in 2026: Emerging Science, and the Future of Bioactive Therapeutics
Executive Overview Peptides have rapidly evolved from a specialized pharmaceutical category into one of the most strategically important therapeutic classes worldwide. Historically limited to applications...
Why Medical Research Professionals Choose MNM ProLabs Compounds
In the modern research landscape, precision is everything. Whether your work involves compound characterization, analytical method development, stability profiling, receptor pathway modeling, or advanced laboratory...
MNM ProLabs Medical Research Department Announces Official Compound Program Launch
Target Launch Date: December 15, 2025 (subject to final QA and supply-chain validation) TAMPA, FL — MNM ProLabs is proud to announce the upcoming launch...
The MNM PROLABS Medical Research Department
Precision, Integrity, and Service — A Veteran-Led Team Driving Non-Clinical Innovation Executive Overview Under the strategic leadership of Marc Ervin, CEO & Founder of MNM PROLABS...
The Role of Research-Use-Only Compounds
Compounds have become one of the most fascinating frontiers in modern biomedical research. These short chains of amino acids act as signaling molecules, metabolic...